Coastal Bridge Advisors’s Processa Pharmaceuticals PCSA Stock Holding History

Coastal Bridge Advisors’s Portfolio PCSA Stock Details PCSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-130	Closed	-$21.7K	–	183
2023 Q4	$21.7K	Buy	130 +25	+24%	+$5.58K	0.01%	172
2023 Q3	$13.1K	Hold	105	–	–	﹤0.01%	171
2023 Q2	$26.1K	Hold	105	–	–	0.01%	164
2023 Q1	$26.3K	Hold	105	–	–	0.01%	166
2022 Q4	$57.8K	Hold	105	–	–	0.02%	163
2022 Q3	$119K	Hold	105	–	–	0.03%	162
2022 Q2	$148K	Buy	105 +40	+62%	+$54.8K	0.05%	142
2022 Q1	$98K	Hold	65	–	–	0.02%	162
2021 Q4	$159K	Buy	65 +10	+18%	+$31K	0.03%	189
2021 Q3	$236K	Hold	55	–	–	0.05%	123
2021 Q2	$225K	Buy	55 +15	+38%	+$58K	0.05%	127
2021 Q1	$218K	Buy	+40	New	+$186K	0.04%	129

Other funds holding PCSA

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MSG

Main Street Group Glen Allen, Virginia $429M AUM 34.03% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

MIM

Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return

Coastal Bridge Advisors's PCSA Position: Q1 2024 in Review

Coastal Bridge Advisors sold out of Processa Pharmaceuticals (PCSA) in Q1 2024, closing a stake of 130 shares — an estimated $21.7K sold.

Coastal Bridge Advisors first reported a position in PCSA in Q1 2021 and held it in 12 quarters. The position peaked at $236K in Q3 2021. 9 funds tracked by Wall St. Rank hold PCSA as of Q1 2024.

Coastal Bridge Advisors reported no remaining Processa Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Coastal Bridge Advisors sold 130 Processa Pharmaceuticals shares in Q1 2024, an estimated $21.7K.
Coastal Bridge Advisors first reported a position in Processa Pharmaceuticals in Q1 2021 and held it in 12 quarters.
Coastal Bridge Advisors's Processa Pharmaceuticals position peaked at $236K in Q3 2021.
9 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q1 2024.

Based on Coastal Bridge Advisors's 13F filing for Q1 2024, filed 15 May 2024.